Press Releases

12/01/2021

IVI partners with SK bioscience to launch new prestigious award for vaccine industry

IVI, SK sign an agreement to launch the ‘Park MahnHoon Award’ to honor individuals and organizations that made contributions to the vaccine industry Award Ceremony will be held annually in April; IVI and SK ‘committed to establish the new award as a prestigious award for […]
12/02/2021

Dr. Sushant Sahastrabuddhe of IVI named ‘Honorary Citizen of Seoul’

Cited for contributions to development of vaccines, joining 8 foreign residents to receive Honorary Citizenship in 2021 Second Honorary Seoul Citizen from IVI   SEOUL, Korea — Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), has been awarded “Honorary Citizenship of […]
12/07/2021

IVI, ADB SEADS, IPK, ICARS, and the Danish Embassy in Korea launch webinar on combatting antimicrobial resistance

    The webinar “Curbing the Invisible Pandemic: Effective Solutions to Collectively Combat Antimicrobial Resistance” was held on December 7, 2021   December 7, 2021 — The International Vaccine Institute (IVI), Asian Development Bank Southeast Asia Development Solutions (ADB SEADS), Institut Pasteur Korea (IPK), the […]
12/17/2021

IVI to establish a European regional office in Sweden

IVI and the Government Offices of Sweden signed a Memorandum of Understanding today to establish the office in Stockholm, creating a European hub for global health research and innovation   December 17, 2021, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international […]